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Allantoic fluids collected  from chick embryos  infected with  the viruses  of 
influenza have been shown to contain at least two types of specific  particles 
which  can  be  separated  by differential centrifugation.  The  larger of these 
particles possesses a  sedimentation constant of between 600 and 800  S  (1--4) 
and is referred to as "600 S component" in the present report.  From the sedi- 
mentation constants and filtration data (3, 5) the diameter of the particlehas 
been calculated to measure between 80 and 120 m/~, a  value which has been 
confirmed by electron microscopy.  The second component is smaller and has 
been found to possess a  sedimentation constant of approximately 30 S  (2, 6) 
indicating a diameter of about 10 mt~ in agreement with electron microscopical 
measurements (6, 7).  Difficulties in the sedimentation by centrifugation of the 
smaller component have been reported (8) and it is possible that the constant of 
30 S may change with increased understanding of the experimental conditions. 
However, the term "30 S component" has been adopted for the present report 
as a convenient designation for the small particle.  In addition, some antigen 
was found to remain in the allantoic fluids after removal of the 600 S and 30 
S components (9,10) which, for the time being, has been called" <30 S fraction." 
This material remained in the supernatant fluid upon repeated centrifugation or 
after centrifugation against sucrose density gradients.  This fraction, which 
behaves serologically like the 30 S component,  has not been studied to any extent. 
Analysis of the properties of the 600  S and 30  S components has revealed 
marked differences.  The 600 S fraction carries the infectivity (1-4), it agglu- 
tinates chicken red cells (1--4), it produces toxic lesions in mice (11,  12), it is 
responsible for the interference  phenomenon  (13),  possesses  immunizing ca- 
pacity (14), and acts as antigen in the complement fixation test (10,  15).  In 
short, the 600 S material has all the attributes of the virus.  The 30 S compo- 
nent, on the other hand,  shows little infectivity, and  this little presumably 
caused by contamination with 600 S particles (2),  it does not agglutinate red 
cells, it is not toxic, does not cause interference, and is active only in the com- 
plement fixation test (10).  The immunizing capacity of the 30 S material has 
not been studied as yet.  This summary reveals only one common property 
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between  the  two  components,  their  ability to react  as antigens  in  the  com- 
plement  fixation  test with specific immune sera against  influenza.  However, 
even this property is based predominantly on different  antigenic  constituents, 
as  has been briefly reported  in a  previous communication  (10).  It is the aim 
of this  report  to  extend  this  observation  and  to  explore  the  r61e played  by 
the  two components  in  the  serological response of human  beings  to  infection 
with or vaccination against influenza viruses. 
Materials and Methods 
Antigens.--(a) Allantoic fluid.  The PR8, F-12, and F-99 strains of influenza A and the 
Lee strain of influenza B virus were used in these experiments.  The virus was propagated in 
the allantoic cavity of 10-day-old chick embryos  during  an  incubation  period of 48 to 72 
hours at 36-37°C.  Thereafter the eggs were chi]led,  and the blood-free allantoic fluids were 
collected.  After centrifugation at 2000 R.P.M. for 10 minutes, to remove larger aggregates of 
debris,  the supernatant  fluids were saved and stored in suitable volumes at  --10°C. until 
needed for the tests.  In later tests the fluids were dialyzed aganst 0.01 M phosphate-buffered 
saline Solution  of pH 7.0 before storage, which reduced the amount of precipitate formed on 
thawing of the frozen preparations.  Normal allantoic fluid was collected and prepared in a 
similar manner. 
(b)  600 S component.  Part of the allantoic fluids,  collected as described, were subjected 
t ° high speed centrifugation at 20,000 R.P.•.  for 20 minutes, a speed sufficient for sedimenta- 
tion of most of the virus.  The supernatant fluids were saved for preparation of the 30 S com- 
ponents.  The sediments were resuspended  in buffered saline solution in a  fraction of the 
volume of the original allantoic fluid.  The particles were sedimented again by centrifugation 
at 20,000 R.r.~r. for 20 minutes, resuspended, and stored in suitable volumes at -- 10°C. until 
used.  The final preparation contained per milliliter the virus particles obtained from 32 to 
64 ml. of allantoic fluid. 
(c)  30  S  component.  The  supernatant  fluids,  after  removal of the bulk of  the  600  S 
particles, were centrifuged at 30,000 R.r.~s. for 60 minutes.  The sediment was suspended in 
~and  to  1,6th  of  the  original  volume  using  buffered  saline  solution and  centrifuged at 
20,000 R.p.~s. for 20 minutes to reduce contamination with 600 S material.  This procedure was 
repeated once or twice until the hemagglutination test became negative.  The antigen was 
stored at  -  10°C. 
(d)  Particulate  components  of  normal  chorio-allantoic  membranes.  Membranes  from 
normal  12-day-old chick embryos were emulsified in buffered saline solution by means of a 
Waring blendor.  After preliminary centrifugation at 5000 R.P.~.  for 30 to 60 minutes the 
supcruatant  fluid was again centrifuged at 20,000  R.P.~.  for 20 minutes.  The pellets were 
suspended in buffered saline solution so that 1 ml. contained the particles obtained from 100 
rag. of wet tissue.  The material was stored at -  10°C. until needed.  The antigen was titra- 
ted against a rabbit serum prepared by injection of these particles.  The optimal dilution of 
antigen giving the highest serum titer was used in the tests. 
(e)  Alcoholic guinea pig kidney extract (Forssman antigen).  The kidneys of several guinea 
pigs were finely minced with scissors and for every gram of tissue 10 ml. of 95 per cent ethyl 
alcohol were added.  The mixture was left at room temperature with frequent shaking for 6 
days.  The extracted tissue was then filtered off and the alcoholic extract stored.  For the 
complement fixation tests it was diluted six-fold by adding saline solution to the extract drop 
by drop under constant agitation.  Further dilutions, if required,  were made in the usual 
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S~ra.--Sera were obtained from subjects exposed experimentally to active influenza viruses 
(PR8, F-12, F-99, and Lee) (16) as well as from a few patients convalescent from the epidemic 
disease.  Specimens taken from the various individuals before exposure or during the acute 
stage of the disease were likewise tested.  Sera were also obtained from subjects before and 
after vaccination with various influenza vaccines.  Among the vaccines used were prepara- 
tions of aUantoic fluid, concentrates prepared by the precipitation with protamine or by sedi- 
mentation in the  Sharples centrifuge.-  In some cases the effect of adjuvants on vaccination 
had been studied (17,  18).  All sera were inactivated at 56°C. for 30 minutes and stored at 
-  10°C. until needed. 
Absorption of the Sera.--For the absorption of sera with the 600 S component an adequate 
amount of this material was sedimented by centrifugation at 20,000 R.p.u.  for 20 minutes. 
The sediment was resuspended in fourfold diluted serum and left at 4°C. for 48 hours.  After 
centrifugation of the mixture at 32,000 a.P.~t, for 90 minutes the supernatant fluid was saved 
and tested for the absence of hemagglutinins and of anticomplementary activity. 
Absorption with the <30 S fraction was carried out according to the technic describedelse- 
where (9).  In a few instances absorption with the 30 S fraction was employed Using a technic 
similar to that used for absorption with the 600 S material except for sedimentation of the 30 S 
fraction at a higher centrifugal speed (30,000 l~.P.~.). 
Unabsorbed serum was carried along in all these procedures as a  control for the possible 
loss of antibodies during some of the steps. 
Complement Fixation Test.--Dilutions of antigen, serum, and complement were mixed in 
equal amounts:  On account of the difficulties in obtaining some of the antigens in sufficient 
quantity, and the number of tests planned for individual sera the volume for the various 
reagents had to be decreased to 0.1 ml. each instead of the 0.2 mi. usually used.  After prelimi- 
nary incubation of the antigen-serum-complement mixtures for 60 minutes at 37°C. 0.2 ml. 
of sensitized sheep cells (2.5 per cent suspension) was added by automatic pipette.  The test 
was read after further incubation for 1 hour and the results recorded as 0  =  no hemolysis. 
tr == trace; wk  =  weak; st ffi strong; ac  =  almost complete; and c  ffi complete hemolysis; 
Two units of amboceptor and 1.3 units of Sharp and Dohme lyovac complement as determined 
by optimal titration technic were employed.  All the usual controls were included in each test. 
Most of the tests concerning the reactivities of the 600 S and 30 S antigens were carried out 
according to optimal titration technic;  i.e.,  varying  dilutions of antigen  were tested with 
varying dilutions of serum on account of the zone phenomena observed with influenza antigens 
(19-21).  In the study of large numbers of sera for the presence of antibodies to the various 
components only optimal dilutions of the antigens were employed (usually 4 to 8 units of the 
600 S and 2 units of the 30 S components) since it had been found in preliminary tests that the 
optima were identical for a number of different sera. 
All other methods have been described elsewhere.  These included agglutination of chicken 
red cells as an indication of viral concentration (Hirst and Pickels  (22)),  the inhibition of 
agglutination of chicken red cells by immune serum (16), and the neutralization test in mice 
(23). 
EXPERIMENTAL 
Serological  Properties  of 600 S  and 30 S  Components 
In  a  previous  publication differences have  been demonstrated  between  the 
600 S and 30 S components of influenza virus preparations by serological means 
(10).  These  became  particularly  apparent  upon  careful  absorption  of  sera 
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the other of the components.  Table I  summarizes an experiment of this kind 
with  two specimens of serum taken from a  patient before and 2 weeks after 
experimental infection with the Lee strain of influenza B virus.  The various 
preparations, i.e. the preinhalation serum, the non-absorbed convalescent serum, 
and the samples absorbed with either a  small amount of the homologous 600 
TABLE I 
Effect of Absorption of Human Convalescent Serum from a Case of Experimental  lnflue~a B 
with Various Fractions Derived  from Influenza A and B Preparation~ 
Serum 
5 A  (Before 
inhalation) 
5 B (2 wks. 
after  inha- 
lation) 
~abbit serum 
against 
normal 
membrane 
particles 
aline  solu- 
tion 
oeruln 
absorbed 
with 
m 
600 S Lee 
<30 S Lee 
600 S PR8 
<30 S PR8 
Normal 
mem- 
brane 
particles 
m 
Sheep ery- 
throcytes 
Titer of serum as measured by 
Complement fixation  test with 
tion of  I  ization 
ag~[luti- J test in  Influenza B (Lee)  Alco- 
natron of [  mice  Normal  bolic 
mere-  guinea  Saline  chicken [  (I,000  ! Allan-  600 S  30 S  brane  pig  solutiot 
erythro-  LDio)  :  toic  corn-  com-  particles  kidney 
cytes  [Lee virus  fluid  ponent  ponent  extract 
<1:16  <1:4  <1:4  <1:4  <1:4  <1:8  <1:8  <1:4 
1:256  1:128  1:64  1:32+  1:64<1:8  <1:8  <1:4 
1:8  <1:4  1:32<1:4  1:32  <1:4 
1:96  1:96  1:32 1:32  1:8  <1:4 
1:256  1:64  1:64  1:32  1:64  <1:4 
1:128  1:64  1:64  1:32  1:64  <1:4 
1:256  1:128  1:64  1:32  1:64<1:8  <1:8  <1:4 
<1:20<1:20  <1:20  1:32G  1:80<1:2¢ 
1:80  <1:20<1:2C 
C*  C  C  C  ¢  C 
* c  =  complete hemolysis. 
S or the 30 S fraction, were tested for their capacity to inhibit the agglutination 
of chicken red cells by the homologous virus, their ability to neutralize the in- 
fectivity for mice, and to fix complement in the presence of infected allantoic 
fluid,  the 600 S and 30 S components.  A comparison of the data listed in Table 
I  shows that exposure to active Lee virus resulted in rises of the antibody titer 
as measured by all tests.  Whereas the various reactions proved negative with 
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using the convalescent  serum.  Absorption of the convalescent  serum with a 
small amount of the homologous 600 S component removed not only the ability 
of the serum to react with the usually employed concentration of the 600  S 
particles (4 to 8 units) in the complement fixation test but also its capacity to 
inhibit  the agglutination of  chicken  erythrocytes and to neutralize the in- 
fectivity of the Lee virus for mice.  On the other hand, the titer of complement- 
fixing antibodies against the original allantoic fluid and the 30  S  component 
was only slightly reduced by absorption of the serum with the 600 S component. 
After absorption of the convalescent  serum  with the  <30 S material of the 
homologous virus the complement fixation reaction with the 30 S component 
showed a marked decrease in serum titer, but not when the original aUantoic 
fluid or the 600 S fraction were used as antigens.  The capacity to inhibit the 
agglutination of red cells and to neutralize the infectivity for mice was only 
slightly impaired in the serum absorbed with the <30 S fraction.  It should be 
noted that in  other,  less extensive  experiments  antibodies against the 30  S 
component have been removed  completely by absorption of the sera with the 
<30 S fraction without appreciably altering the reaction of the serum with the 
600 S component.  Similar results were obtained, using the various fractions of 
the PR8, F-12, and F-99 strains of influenza A. 
In control tests the convalescent  serum was absorbed  with  the  two corm- 
sponding components of the heterologous  type of virus; i.e., in  the  cited ex- 
periment with the fractions derived from the PR8 strain of influenza A.  No 
significant changes occurred in the various tests following absorption with these 
materials.  Such slight decreases in titer as were noted in these control tests 
as well as in some tests with the components of the homologous virus may well 
be explained by the limits of the experimental technics.  The small volumes of 
the reagents necessarily  employed in  the various tests did  not  favor their 
accuracy.  Furthermore, preparations of one of the particles were never en- 
tirely free of those of the other size. 
In other sets of controls the absence from the sera of antibodies to normal 
chick and Forssman antigens was ascertained.  In the experiment  recorded in 
Table I the patient's sera did not react with particulate components of normal 
chorio-allantoic  membranes nor with alcoholic  extract of guinea pig kidney 
(Forssman antigen).  On the other hand, serum  of a  rabbit immunized with 
normal membrane particles reacted in high dilution with the homologous anti- 
gen or with the kidney extract but not to any appreciable extent with the dilu- 
tions of the influenza preparations used in the recorded  test.  Absorption  of 
the rabbit serum  with sheep erythrocytes removed  all antibodies  against the 
guinea pig kidney extract but only part of the antibodies to the normal mem- 
brane particles,  indicating that both Forssman and particle-specific antibodies 
were involved in the reaction.  It should be stated here that other preparations 
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particles  serum in agreement with the observations  of others (8, 24) and that 
a few human sera were encountered in this study which contained complement- 
fixing antibodies  against particles  derived from normal membranes but rarely 
against Forssman antigen.  Some of these were preinhalation or prevaccina- 
tion sera.  In other instances  these antibodies developed  as a  result of vac- 
cination.  These occasional findings  demonstrate the possible  interaction of 
such non-specific reactions  in complement fixation tests for influenza and ne- 
cessitate  adequate controls  to guard against them.  All sera,  therefore,  were 
tested against the normal membrane particles  as well as with Forssman anti- 
gens.  A sample of protein prepared by high speed centrifugation from normal 
allanotic fluid (8) was kindly supplied by Dr. Knight.  It did not react in the 
complement fixation test using human influenza convalescent sera. 
The  above  experiment  demonstrated  that  definite  serological  differences 
existed between the two components.  However,  in further tests, employing 
various technics, it could be shown that the 600 S component contains some of 
the 30 S-type antigen.  Fresh samples of the convalescent  serum used in the 
preceding experiment  were absorbed  either with a small amount of  the 600 S 
component or with the 30 S fraction.  The absorbed  sera were then tested in 
varying dilutions with increasing  concentrations of  the two fractions.  The 
results of this experiment  are recorded  in Table II.  The unabsorbed serum 
showed the different relationships frequently encountered in the optimal titra- 
tions with  the  two fractions.  With increasing  concentration of the  600  S 
component the antibody titer rose until the maximum was reached  with the 
use of 8 to 16 units of antigen.  The opposite held true for the 30 S component 
since the minimal reacting dose of antigen gave the highest serum titer.  A line 
drawn through the last dilutions of serum giving complete fixation of comple- 
ment ("0" in the table)  in the presence of various concentrations of the 600 
S particles described a wide curve,  whereas  a similar line drawn through the 
end points in the 30 S reaction revealed a sharply angular shape. 
Absorption of the serum with the 600 S fraction produced a decrease in anti- 
gen titer (shift of the minimal dose from 1:64 to 1:4), whereas  the optimal 
serum titer showed practically no change.  This finding could be explained by 
the  presence of at  least two distinct antigens in the 600 S particle.  One of 
these  exceeded  the  other  markedly in  quantity  or  sensitivity.  Therefore, 
removal of antibodies against the dominant antigen could be achieved  without 
markedly altering the reaction with the lesser antigen.  The pattern of this 
remaining activity did not show the "fa.lling off" curve considered character- 
istic of the 600 S-specific antigen but revealed rather the same optimal relation- 
ships observed with the 30 S component.  Absorption  of the serum with the 
30 S component again, removed the antibodies against these particles but left 
the reaction with the 600 S-specific antigen unaltered. 
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that of the 30 S fraction as the one recorded in Table II.  Different prepara- 
tions were found to vary somewhat in this respect (see Table V).  This varia- 
tion may depend in part on the amount of the 30 S-type antigen linked to the 
600 S particle.  The quantity of the 30 S antigen in the 600 S  component may 
depend, in turn, on the conditions under which the virus was cultivated; i.e., 
Demonstration 
Convalescent  serum 85  B 
(experimental  influenza  B) 
Absorbed with 
600  S  ;compo- 
nent (Lee) 
30 S component 
(Lee) 
Saline solution 
TABLE  II 
f 30 S Antigen in Higher Concentrations of 600 S Particles 
Antigens 
600 S component  (Lee) in dilutions 
Initial  ( ndi- 
dilution i 
se:ufra  ~ted[ h 
1:4  0  0 
1:8  i 0 
1:161  0  C 
1:32  + 0 
1:64  0 
1:128i  ~t 
1:4  ]  0  0 
1:8  0 
1:16  0 
1:32[  0 
1:64  tr 
1:4 
1:8 
1:16i 
1:32 
1:64 
C  C 
i 
'  1:4  1:  t:16  1:3  .:64 
0[0  0  0  0 
0  ]  0  0  0  0 
0  0  0  0  0 
0  0  0  0  tr 
0:0  0  tr  ac 
0[  tr  wk  c 
0  tr  st  st 
O~  tr  st  c 
0  tr  st  c  c 
01w  ac  c 
0  a¢  c  c 
0  0  0  0  0 
)o  o  o  o  o 
0  0  0  0  0 
I  o  c  0  0  wk 
tr  0  0  tr  ac 
C  C  C  C  C 
30 S component (Ice) 
in dilutions 
at.~nl~" 1:2  t:41  1:8 I 1:1 
(  0  i  } tr  .  a< 
(  0  tr  a( 
(  0  tr  I a( 
(  0  0  t  I  tr  a{ 
/ 
tl  0  0  l  wt  a~ 
(  0  wl  a< 
(  0  wl  ac 
(  0  wl  c 
tJ  0  wl  c 
c  tr  tr  [ st  c 
{ 
tr  st  ac [ c 
J 
WJL  aC  C 
st  C  C 
C  C  C 
C  C  C 
C  C  C  C  C 
S~ 
sol~- 
t~n 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
0  =  no hemolysis; tr =  trace; wk  == weak; st =  strong; ac  =  almost complete; c  =~ com- 
plete hemolysis. 
on the concentration of the inoculum used for the chick embryos, the duration 
of the incubation period, and possibly other factors. 
The experiment recorded in Table  II indicated,  then,  that  30  S  material 
formed part of the 600 S component.  Absorption of convelescent sera with an 
excess of the 600 S fraction should,  therefore, remove the antibodies against 
both components.  This was actually the case as shown in Table III.  On the 
other hand, absorption of the convalescent serum with an excess of 30 S ma- 266  COMPLEMENT  FIXATION ANTIGENS OF  INFLUENZA 
terial removed the reaction with  the 30  S  component only and not that with 
the 600 S-specific antigen. 
Further proof of the presence of 30 S antigen in the 600 S particles was ob- 
tained by liberating 30  S  material from the 600  S  component by mechanical 
means.  A  large batch of the 600 S component was prepared in the usual man- 
TABLE III 
Effect of Massive  Absorption  witk the 600 S  Fraction on 30 S Antibody 
Convalescent serum 97 B 
(experimental influenza  A) 
Absorbed  with 
Antigens 
500  S  component (F-99)  30 S component (F-99) 
in dilutions  in dilutions 
Saline 
Initial  solution 
dilution  1:8  1:16  1:32  1:64  1:8  1:1  1:32  1:64 
of serum 
1:8  0  0  0  0  0  0  0  0  c 
1:16  0  0  0  0  0  0  0  0  c 
1:32  0  0  0  0  0  0  0  0  c 
1:64  0  0  0  tr  tr  tr  0  0  c 
1 : 128  tr  tr  wk  wk  ac  st  tr  0  c 
1 : 256  st  st  ac  ac  c  c  ac  wk  c 
600 S  component  1:4  st  ac  ac  ac  st 
(F-99) in excess  1  :  8  ac  ac  c  c  c 
1:16  c  c  c  c  c 
1:32  c  c  c  c  c 
1:64  c  c  c  c  c 
1:128  c  c  c  c  c 
1 : 256  c  c  c  c  c 
30  S  component  1:8  0  0  0  0  st 
(F-99)  1 : 16  0  0  0  0  ac 
1:32  0  0  0  0  c 
1:64  tr  0  0  0  c 
1:128  st  st  wk  wk  c 
Saline  solution  c  c  c  c  c 
st  wk  wk  c 
C  C  C  C 
C  C  C  C 
C  C  C  C 
C  C  C  C 
C  C  C  C 
C  C  C  C 
C  C  C  C 
C  C  C  C 
C  C  C  C 
C  C  C  C 
C  C  C  C 
C  C  C  C 
ner and divided into two lots.  One part was subjected to vibration for 1 hour 
in  the  treatment vessel of a  magnetostriction  oscillator at  90,000  cycles per 
second (25), the other part was used as control.  Both the untreated and  the 
vibrated suspensions were centrifuged at 20,000 R.p.xt. for 20 minutes,  a  pro- 
cedure insui~cient for the sedimentation of the 30 S material but adequate for 
the almost complete removal from suspension of the 600  S  component.  The 
supernatant fluids of the native and sonically treated material, as well as the 
untreated and vibrated 600 S components were used as antigens in the comple- M.  WIENER,  W.  HENLE,  AND  G.  HENLE  267 
ment fixation test.  The results are recorded in Table IV.  It is evident from 
the table that sonic  vibration released more serologically active material from 
the  600  S  particle  than  was obtained in  the  untreated  specimens.  This re- 
leased material behaved like the 30 S component since it was not sedimented by 
centri/ugation at 20,000 l~.l,.X~, and reacted with antibodies to 30 S material; 
i.e., with a serum from which antibodies to the 600 S-specific antigen had been 
removed by absorption.  This result furnishes evidence that the 30 S component 
can be released from the 600 S particle. 
TABLE IV 
Liberation of the 30 S Antigen  from the 600 S Fraction by Supersonic Oscillation 
Convalescent  serum 85 B 
(experimental  influenza  B) 
Absorbed with 
600 S component (Lee) 
Saline solution 
Initial 
dilution 
of  serun 
1:4 
1:8 
1:16 
1:32 
1:64 
1:128 
1 : 256 
1:4 
1:8 
1:16 
1:32 
1:64 
1:128 
Antigen in optimal dilution 
600  S  component 
(Lee) 
Native  Sonic  Native 
1:8  1:4  Undiluted 
o  o  o 
o  o  tr 
0  0  tr 
0  0  tr 
0  wk  tr 
st  c  st 
c  c  c 
st  wk  0 
ac  ac  tr 
c  c  tr 
c  c  wk 
c  c  c 
C  C  C 
c  c  c 
Supernatant  fluid 
Sonic 
1:2 
o 
o 
o 
o 
o 
st 
C 
o 
o 
o 
o 
tr 
c 
30 S 
component 
flee) 
Native 
1:4 
o 
o 
o 
o 
o 
o 
c 
o 
o 
o 
o 
tr 
C 
Saline 
solution 
Differences  in the Antibody Response of Human Beings to the  600 S  and 30 S 
Components 
The data presented thus far demonstrate the existence of serological differ- 
ences between the two components, the 600 S and 30 S fractions.  In  further 
studies it became apparent that the antibody response of human  beings varied 
in regard to these two components.  Table V  shows, as an example,  optimal 
antigen-antibody titrations with sera of two human subjects taken before and 2 
weeks after experimental exposure to active influenza A  virus.  Patient  110 
responded to the exposure with high fever (104°F.)  and  developed antibodies 
against both the 600 S and 30 S components.  On the other hand,  the convales- 268  COMPLEMENT  FIXATION ANTIGENS O1~  INTLUENZA 
cent serum of patient 108, who showed no febrile reaction following the exposure, 
contained antibodies against the 600 S component only and not against the 30 
S fraction. 
Further tests furnished ample evidence that the formation of antibodies  to 
the 30 S component was a fairly regular result of the natural or experimental 
TABLE  V 
Difference in Antibody Response to the 30 S Component after Experimental Exposure to Aai~e 
Virus of Influenza A 
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disease, whereas failure of antibody production against the 30 S component was 
rather the rule following vaccination and only infrequently  noted after exposure 
to active virus.  Support for this statement is given in Table VI.  This table 
shows the incidence of reactions  with the 600 S and 30 S components of the 
PR8 and Lee strains in human sera, taken either before and after epidemic in- 
fection or inhalation of active virus of the homologous type (90 pairs of sera) 
or before and after vaccination with inactivated viruses  of influenza A and B 
(69 pairs).  The individual sera were tested simultaneously with the PR8 and M.  WIENER,  W.  HENLE,  AND  G.  HENLE  269 
Lee components in optimal dilution as well as with normal membrane particles 
and Forssman antigen.  As can be seen in the table slightly more than 50 per 
cent of the preinhalation and prevaccination sera reacted with the 600 S com- 
ponents of influenza A and B.  After the experimental or epidemic disease, or 
after vaccination between 93 and 100 per cent of the sera gave positive  tests 
with this fraction.  On the other hand, the incidence of reactions with the  30 
S components of influenza A virus rose from 24 to 76 per cent following inhala- 
tion of active virus of the homologous type or epidemic disease, but only from 
15  to 23  per cent following vaccination.  In the case of exposure to the Lee 
TABLE VI 
Incidence of Reactions with 600 S and 30 S Components in Human Beings Following Epidem@ 
and Experimental Exposure to Active Virus or Vaccine.lion with Inactive Virus 
Sera 
Preinhalation  (or pre- 
epidemic) 
Postinhalation or post- 
epidemic) 
Prevaccination 
Postvaccination 
Preinhalation 
Postinhalation 
Prevaccination 
Postvaccination 
Viru 
used f 
antlge 
PR~ 
PR~ 
Lee 
Lee 
Antigens 
600 S component  30  S  component 
Positive 
No. of 
subjects 
27 
54 
37" 
65 
16 
32 
41 
69 
Per 
cent 
46.5 
93 
54.5 
96 
50 
AO0 
59.5 
100 
Negative 
No. of  Per 
subject~  cent 
31  53.5 
4  7 
31  45.5 
3  4 
16  50 
0  0 
28  40.5 
0  0 
No. of  Per 
subjects  cent 
14  24 
44  76 
10  15 
16  23 
3  9 
31  97 
15  22 
28  40.5 
Positive  Negstive 
No. of  Per 
subjects  cent 
44  76 
14  24 
58  85 
52  77 
29  91 
!  3 
54  78 
41  59.5 
strain of influenza B  the incidence of positive tests with the homologous 30 S 
component rose from 9 to 97 per cent following inhalation of active virus, where- 
as the corresponding figures for vaccination showed only an increase from 22 to 
40 per cent.  In examining the clinical records of the fourteen subjects,  whose 
sera did not react with the 30 S component after inhalation of influenza A virus 
it was found that eight had no signs or symptoms, the other six reacted with an 
elevation of temperature but showed only insignificant or no rises in  neutraliz- 
ing antibodies as measured by the  inhibition  of hemagglutination.  The one 
individual in the Lee inhalation  series showed  a  febrile response and a  slight 
rise in neutralizing antibodies.  On the other hand,  not all subjects responding 
with 30 S antibodies had febrile reactions following the inhalation of virus. 
These figures suggest that antibodies to the 30 S component are formed in a 270  COMPLEMENT  ]fIXATION  ANTIGENS OF IBFFLUENZA 
high  percentage of subjects following exposure to active  virus under either 
experimental or epidemic conditions, but only rarely following vaccination with 
inactivated virus.  These differences in the two groups of sera were actually 
more striking.  Table VI gives merely the incidence of sera reacting with the 
two components regardless of the concentration of the antibodies.  However, 
considering the Liters against the various antigens further differences became 
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Fzo.  1.  Correlation between 600 S  and 30 S  antibodies in sera taken from subjects before 
and after exposure  to or vaccination with influenza A virus. 
apparent among the two groups.  In Figs.  1 and 2 the 600 S antibody titers 
were plotted against the 30 S titers of individual sera.  Each dot represents, 
therefore, the results obtained with one serum, giving the anti-600 S titer on the 
ordinate and the titer of 30 S antibodies on the abscissae.  Fig.  1 records the 
results of the influenza A reactions separately for the different types of sere; 
i.e.,  specimens  taken  before and  after experimental exposure and  epidemic 
disease and sera taken before and after vaccination.  The corresponding values 
for the influenza B  series are shown in Fig. 2. 
The conclusions drawn from these two figures may be summarized as follows: M. WIENER,  W. HENLE,  AND  G. HENLE  271 
The preinhalation and prevaccination sera showed a  similar incidence of sere 
with 600 S and 30 S antibodies, or with 600 S antibodies only.,~ Postinhalation 
sera  possessed  anti-30  S  titers  equal  to  or  not  less  than  ~  that 
of  the  600  S  antibody  levels.  This  is'  demonstrated  by  the  fairly 
narrow diagonal band of dots in Figs. lb  and 2b.  Among the postvaccina- 
tion  sera  only  a  few  showed  anti-30  titers  of  similar  height  as  the 
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FIO. 2. Correlation  between 600 S and 30 S antibodies  in sera  taken from subjects  before 
and after  exposure to  or vaccination  with  influenza  B virus. 
anti-600 S levels and the dots were spread,  therefore, over the whole upper 
triangular field  of the chart (Figs, /g and 2d).  If there were 30 S antibodies 
they were present usually only in low titer  as compared to the levels  observed 
in the postinhalation sera.  Some of the cases in the vaccination group who 
possessed  antibodies  against  the  30  S  component  before vaccination main- 
mined the same antibody level to the 30 S fraction after vaccination but showed 
an increase in the anti-600 S titer.  Only a  relatively small number of individ- 
uals, as shown in Table VI,  acquired anti-30 S by vaccination.  It should be 
pointed out that, thus far, only sera from individuals injected with one of three 272  COMPLEMENT  ~IXATION ANTIGENS  01~ INFLUENZA 
different vaccines have been studied.  It is possible that other vaccines pre- 
pared by the same or different methods may induce formation of 30 S anti- 
bodies more readily. 
The Significance  of 600 S  and 30 S  Antibodies 
Discrepancies between the results of neutralization tests in mice and the com- 
plement fixation reaction have been  reported repeatedly (26-31).  No such 
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FIG.  3. Correlation  between antibody titers  obtained  in  the inhibition  of  hemagglutination 
and complement fixation with the 600 S component in the case of influenza A, 
studies are available as yet as to comparisons  between  the inhibition of the 
hemagglutination  and the complement  fixation reactions.  However, since the 
neutralization and inhibition tests were found to be correlated  (32) it may be 
expected that similar discrepancies, as noted between neutralization and com- 
plement fixation tests, will be observed also between  the inhibition and com- 
plement fixation reactions. 
The data  obtained with the  two  separate  components  of influenza  virus 
preparations as antigens were analyzed in regard to these relationships.  In 
Figs. 3 and 4 the anti-600 S titers as determined by complement fixation tests 
were plotted against the antibody levels measured in the inhibition of hemagglu- M.  WIENER)  W.  HENLE)  AND  G.  HENLE  273 
tination.  Fig. 3  contains the data obtained in the influenza A  reactions, Fig. 
4 those for influenza B.  Differentiation was made in these figures b.etween sera 
containing 30 S antibody and those lacking measurable amounts of it, as well 
as between sera taken before and after experimental exposure and vaccination. 
In contrast  to the postinhalation  and postvaccination  sera,  specimens  taken 
before the exposure  to or immunization  with the influenza viruses  represent 
samples from populations with unknown influenza histories, involving possibly 
avariety of different strains of the agents.  It is possible that for this reason sera 
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Fto. 4.  Correlation  between antibody titers obtained L~ the inhibition  of hemagglutination 
and complement  fixation with the 600 S component in the case of influenza B. 
taken at a given time interval following contact with a known strain of virus 
yielded  dearer results.  In  the absence  of 30  S  antibodies  these sera gave a 
fairly close correlation between  the  inhibition and the  600  S  antibody  titers 
which is expressed in the rather narrow diagonal band of dots in Figs. 3 b and 
4b.  The number of sera studied, thus far,  is limited and does not justify cab 
culation  of the geometric mean anti-600  S  levels for a  given inhibition  titer. 
In spite of this limitation it seems clear that a linear relationship exists between 
the two reactions approximately expressed in the diagonal  lines.  Most dots 
fall either on or one step above or below these lines.  Only three dots, both in 
the PR8 and Lee series, were outside this range.  It is felt, that these irregu- 274  COMPLEMENT  FIXATION  ANTIGENS  OF  INFLUENZA 
larities may be the result of variations in the individual tests and of the technical 
diificulties discussed above.  Under the experimental conditions employed, the 
titer obtained by the inhibition of hemagglutination was about 32 times that 
of the anti-600 S titer in the case of the tests with PR8 virus and about 16 times 
greater in the case of the Lee strain. 
In contrast to the postvaccination or postinhalation sera which were free of 
measurable quantities of anti-30 S, those containing this antibody did not show 
such a  close relationship between the two tests.  In comparing these charts 
(Figs. 3d and 4d)  with the diagonal band of dots discussed above,  it can be 
seen that a much wider spread of dots was obtained particularly in the case of 
TABLE  VII 
Incidence of Significant Rises in Antibody Titers* as Measured by Various Tests in Febrile Case~ 
Following Experimental Exposure or Epidemic Disease 
Inhibition 
of hemag- 
glutination 
+ 
+ 
+ 
+ 
Complement fixation with 
6oos  30S 
component  component 
+  + 
+ 
-  + 
m 
+  + 
+ 
-  + 
torsi No. of cases  .... 
PR8 antigens 
No. of  Per cent 
c&se$ 
17  48.5 
3  8.5 
0 
0 
4  11 
2  6 
2~  6 
7  20 
35  10o 
Lee antigens 
No. of  Per Cent 
cases 
18  75 
0 
0 
0 
1  4 
1  4 
2t  8.5 
2  8.5 
24  100 
Total 
No. of  Per cent 
c&se$ 
35  6O 
3  5 
0 
0 
5  8 
3  5 
4  7 
9  15 
59  100 
* Fourfold rise or better. 
:~ One of these sera showed a  high titer in the inhibition of hemagglutination before ex- 
posure. 
thereactions with the  PR8 preparations.  No attempt was made to differ- 
entiate between different heights of the anti-30 S titers in these charts. 
In studying the preinhalation and prevaccination sera, which did not con- 
rain anti-30 S (Figs. 3 a and 4a) it may be seen that many do not seem to follow 
the same pattern as observed with the postinhalation and postvaccination sera. 
Some of the sera contained appreciable concentrations of antibodies to the 600 
S component but very low inhibition titers, particularly in the case of the in- 
fluenza B tests.  Non-specific reactions with chick proteins and Forssman and 
Wassermann antigens have been excluded since only very few of the sera re- 
acted with these antigens.  The possibility of other specific antigens remains to 
be explored. 
The above data indicate  that  the inhibition  of hemagglutination  and  the 
complement fixation reactions with 600 S-specific antigens  measure probably M'. WIENER, W. HEN"LE, AND G. HENLE  275 
the same antibodies.  Discrepancies  between  the two tests may be observed 
if the sera  contain anti-30  S.  The r61e played by the two components was 
further studied in comparing  the various reactions  in their diagnostic value. 
Since only ten pairs of sera from epidemic cases were available and most tests 
were performed with sera  taken from subjects with febrile reactions after ex- 
perimental exposure to active influenza virus (54 cases) the results recorded in 
Table VII must be considered as preliminary until further studies in large series 
with sera from epidemic  cases have been  completed.  As can be seen in the 
table,  65 per cent of all epidemic  and experimental cases  showed significant 
rises in antibodies of four fold or greater in the inhibition of hemagglutination 
as well as in the complement fixation tests with the 600 S and 30 S preparations 
as antigen.  Fifteen per cent of the cases failed to show a response in any of the 
tests or gave only suggestive results.  Twenty per cent of the cases gave signif- 
icant increases in the complement fixation reaction but only doubtful or nega- 
tive responses in the inhibition test.  In four of these subjects,  who possessed 
partly high initial titers in the inhibition test, the increase in the complement 
fixation reaction was based solely on the 30 S component.  All individuals who 
failed to show  a  significant  response by complement fixation technic likewise 
revealed no significant increase in titer in the inhibition test.  The complement 
fixation test, therefore, may be of additional value in the diagnosis of influenza. 
DISCUSSION 
By using centrifugation technic Hoyle and Fairbrother (33) showed that the 
supematant fluid of suspensions of mouse lungs infected with influenza A virus 
contained a "soluble antigen" whereas  the separated infectious  "elementary 
bodies" failed to react in the complement fixation test.  Lennette and Horsfall 
(34) confirmed the presence  of a soluble antigen in mouse lungs but noted in 
addition that the virus particles  always contained some complement fixation 
antigen.  No  serological differences  between  the  two fractions  were  noted. 
The reported sedimentation data strongly suggest that this "soluble antigen" 
is identical with the 30 S component of infected allantoic fluids.  Observations 
made simultaneously by Friedewald  (15) and in this laboratory (9)  showed 
definite physical and  biological  differences  between  two  antigenic fractions 
derived from allantoic fluids by differential centrifugation.  The data summa- 
rized in the present paper demonstrate distinct serological differences between 
the two particulate components  isolated from infected allantoic fluids.  The 
larger of the particles,  the 600 S component, which possesses all the attributes 
of the virus, as stated in the introduction to this paper, can be differentiated 
from the 30 S component by the pattern of the optimal antigen-antibody re- 
actions, by cross-absorption  of sera with the two particles,  and by the use of 
human sera  reacting either with the 600  S  component  only  (mostly post- 
vaccination sera), or with both particles (mostly convalescent sera). 
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S component is different from that of the 30 S fraction.  It was possible, how- 
ever, to demonstrate in the larger particle the presence of some antigen identical 
with that of the 30 S component.  This was accomplished by the use of high 
concentrations of the 600 S component in the complement fixation tests with 
sera absorbed  by small amounts of 600 S particles,  which retained antibodies 
to the 30 S component; or by the release of 30 S antigen from preparations of 
the 600 S particle by intense sonic vibration.  Furthermore, in earlier experi- 
ments strain-specific as well as type-specific reactions have been shown in tests 
with the 600 S components of influenza virus by the use of animal or human 
sera (10, 35).  Thus the 600 S particles  contain a number of antigenic constit- 
uents, which are in part specific for the 600 S component (type-specific as well 
as strain-specific),  in part identical with the antigen of the 30 S fraction. 
The 30 S antigen appears to be type-specific only and not strain-specific (10). 
However, 30 S preparations of a greater number of strains have to be studied 
before this point can be accepted.  Since it seems very likely that the "soluble 
antigen" in suspensions of infected mouse lungs is identical with the 30 S prepa- 
ration of allantoic fluid the data reported by Lennette and Horsfall (36) can 
be taken as additional evidence for the absence of strain-specificity of this frac- 
tion. 
The relation of the complement fixation tests with the various components 
to other serological reactions  has not been studied to any extent.  However, 
absorption of sera  with the 600  S particles  rendered  them ineffective in the 
neutralization  test  and  in  the  inhibition  of  hemagglutination.  Removal 
from the sera of the 30 S antibodies causes only insignificant changes in these 
reactions.  It is obvious, then, that the complement fixation reaction with the 
30 S component does not assay antibodies involved in the tests of neutraliza- 
tion or inhibition of hemagglutination.  On  the other hand, complement  fixa- 
tion tests with the 600 S component with sera free of 30 S antibodies  gave a 
fairly close correlation to the inhibition test indicating that identical antibodies 
were determined under these  conditions.  This correlation  seems to be prac- 
tically independent of the strain of virus used since human sera show only slight 
strain-specific  differentiation which  can  be  demonstrated in some  instances 
only after absorption of the ser~ with heterologous strains (10, 35). 
It is likely that the differences in the relative concentration of the two com- 
ponents in infected allantoic fluids or other virus preparations, used as antigens 
in the complement fixation  tests, as well as the variation in the response  of 
human beings to these antigens can account for some of the discrepant findings 
reported in the literature.  Thus, Smith (26) and Fairbrother and Hoyle (27) 
in presenting the first two reports on complement fixation reactions in influenza, 
showed differences between  the neutralization and complement  fixation tests. 
They suggested that neutralization of the virus was caused by a specific anti- 
body which did not cause complement fixation, while a  "group antigen" was M.  WIENER,  W.  HENLE,  AND  G.  HENLE  277 
active mainly in the complement fixation and to a slight extent only in cross- 
neutralization.  Similar  discrepancies  were  subsequently reported  by others 
(28-31).  Differences in the zone phenomena encountered in sera of different 
species by Nigg et al.  (21) may also depend on the predominance of one or the 
other of the antigenic components or on the presence  or absence  of the 30 S 
antibody. 
Differences in the response of human beings to either infection or vaccination 
have been noted in a few cases by Smith (26), and by Fairbrother and Hoyle 
(27) in comparing human convalescent with horse hyperimmune sera.  In the 
light of the above experiments it appears likely, that the antigens used by these 
authors were predominantly  composed of 30 S and insufficient in 600 S particles. 
The same may account for the failure to demonstrate rises  in complement- 
fixing antibodies in man following vaccination as reported by Morrison,  Shaw, 
Kenney, and Stokes  (37). 
The fact that the 30 S antibodies appear most frequently upon exposure to 
active virus and only occasionally following vaccination may be of assistance 
in epidemiological surveys, when it may be necessary to differentiate between 
recent infections and residual antibodies from previous vaccinations.  The 30 
S reaction may be of additional value too, in the diagnosis of influenza since it 
may give a greater incidence of positive results (significant rises in antibodies) 
than the test for inhibition of hemagglutination.  It may show an increase in 
titer, on occasion, in subjects with high titers in the inhibition test which did 
not increase  after infection.  These suggestive  observations  made mainly in 
cases of experimental influenza require  confirmation on larger scale with sera 
from cases of the epidemic disease. 
S~RY 
Two types of specific particles can be obtained from allantoic fluid prepara- 
tions of influenza A and B virus.  The larger particle which possesses all the 
attributes of the virus and which shows a sedimentation constant of about 600 
S was compared with the smaller component (30  S)  by complement fixation 
technic. 
The 30 S component can be differentiated from the 600  S particle by the 
patterns of the optimal antigen-antibody relationships and by cross-absorption 
of the sera with the two particles. 
Some of the 30 S-type antigen can be demonstrated in higher concentrations 
of the 600 S particles by the use of sera containing only anti-30 S, i.e., sera care- 
fully absorbed with 600 S component.  Also, upon sonic vibration of the 500 
S particle, SerologicaIIy active material was released which behaved in every 
respect like the 30 S antigen. 
The response of human beings to these antigens was found to vary.  Anti- 
bodies to the 30 S component developed in the majority of subjects exposed to 278  COMPLEMIENT ~IXATION ANTIGENS OF INFLUENZA 
active virus either under epidemic or experimental conditions, but only rarely 
following vaccination with three different vaccines. 
In selecting sera without 30 S antibodies a fairly close correlation between the 
antibody  titers  obtained  by inhibition  of hemagglutination  and  complement 
fixation with the 600 S component was obtained.  The presence of 30 S anti- 
bodies prevented  such a  correlation. 
The  reaction with  the 30 S  antigen  may be of value  in  the diagnosis  and 
study  of  the  epidemiology of influenza. 
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